SIRT1 and neoplasm: Given its central role in oxidative stress adaptation and therapeutic resistance, the pharmacological inhibition of SIRT1 has emerged as a promising approach to disrupt tumor survival mechanisms and enhance the efficacy of existing treatments [82].